IBM Falls on Accounting Concerns

NVIDIA slides on a further selloff; Honeywell taps new CEO; plus more of today's stocks in the news

King Pharmaceutical (KG ) posted $0.31 vs. $0.24 Q4 EPS on a 44% revenue rise and remains comfortable with projected ranges for estimated net sales of Altace, as well as total revenue and EPS from operations for 2002.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.